| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.19 | 0.0003 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.17 | 0.0006 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.005 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.007 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.008 |